Heart Failure

Frontiers in Cardiology

  • Akira Kitabatake
  • Shigetake Sasayama
  • Gary S. Francis
  • Hiroshi Okamoto
Conference proceedings

Table of contents

  1. Front Matter
    Pages II-XIV
  2. New Insights in the Pathophysiology of Heart Failure

  3. Heart Failure and Cardiac Sudden Death

    1. Front Matter
      Pages 103-103
    2. Minoru Horie, Hidetada Yoshida, Hideo Otani, Tomohiko Ai, Toshihisa Nishimoto, Tetsuya Haruna et al.
      Pages 105-113
    3. Ko Takeichi, Naoki Matsuda, Hiroshi Kasanuki
      Pages 115-120
  4. Medical Treatment of Heart Failure: Beyond ACE Inhibitors

    1. Front Matter
      Pages 127-127
    2. Takashi Miyauchi, Yasuro Sugishita
      Pages 161-174
    3. Luigi Saccà, Antonio Cittadini, Salvatore Longobardi, Serafino Fazio
      Pages 175-181
    4. Masafumi Kitakaze, Tetsuo Minamino, Koichi Node, Seiji Takashima, Hiroharu Funaya, Tsunehiko Kuzuya et al.
      Pages 183-195
  5. Gene Therapy for Heart Failure: Current Status and Future Prospects

    1. Front Matter
      Pages 197-197
    2. Tomie Kawada, Yoko Nakatsuru, Aiji Sakamoto, Toshiyuki Koizumi, Wee Soo Shin, Mikio Nakazawa et al.
      Pages 199-208
    3. Dong-Ju Choi, Walter J. Koch, Howard A. Rockman
      Pages 209-218
    4. Ryuichi Morishita, Motokuni Aoki, Hidenori Nakagami, Yoshiaki Taniyama, Kei Yamamoto, Hidetsugu Matsushita et al.
      Pages 219-226
  6. Surgical Treatment for Heart Failure

    1. Front Matter
      Pages 235-235
    2. Hisateru Takano, Takeshi Nakatani
      Pages 237-248
  7. Back Matter
    Pages 255-261

About these proceedings


Remarkable progress has been made in understanding and treating heart failure. Among other developments, angiotensin-converting enzyme inhibitors and b blockers have been found to have beneficial therapeutic effects, reinforcing the view that heart failure may be both a hemodynamic and a neurohumoral disorder. The Japanese Heart Failure Society was established to curb the threat of heart failure through research, education, and clinical practice. At the Societys 2nd Annual Scientific Meeting in Sapporo, molecular biologists, physiologists, clinicians, surgeons, and researchers in related fields met to strengthen professional bonds for the ultimate goal of preventing death from heart failure. This book contains presentations from the Sapporo conference that provide new insights into heart failure in the areas of pathophysiology, cardiac sudden death, medical and surgical treatment, and promising new gene therapy.


Angiotensin II Arrhythmias Beyond ACE Inhibitors Beyond Cardiac Transplantation Gene Therapy Heart Failure Ischemia Molecular Mechanism Sudden Death

Editors and affiliations

  • Akira Kitabatake
    • 1
  • Shigetake Sasayama
    • 2
  • Gary S. Francis
    • 3
    • 4
  • Hiroshi Okamoto
    • 1
  1. 1.Department of Cardiovascular MedicineHokkaido University Graduate School of MedicineKita-ku, SapporoJapan
  2. 2.Department of Cardiovascular MedicineKyoto University Graduate School of MedicineSakyo-ku, KyotoJapan
  3. 3.Coronary and Intensive Care UnitThe Cleveland Clinic FoundationUSA
  4. 4.Department of CardiologyOhio State UniversityClevelandUSA

Bibliographic information